Abstract:Background: The N-myc downstream-regulated gene (NDRG) family, NDRG1-4, has been involved in a wide spectrum of biological functions in multiple cancers. However, their prognostic values remain sparse in gastric cancer (GC). Therefore, it is crucial to systematically investigate the prognostic values of the NDRG family in GC. Methods: The prognostic values of the NDRG family were evaluated by Kaplan-Meier Plotter and SurvExpress. The mRNA of the NDRG family was investigated in The Cancer Genome Atlas (TCGA). Transcription factors (TFs) and miRNAs associated with the NDRG family were predicted by NetworkAnalysis. The prognostic values of DNA methylation levels were analyzed by MethSurv. The correlation between immune cells and the NDRG family was evaluated by the Tumor Immune Estimation Resource (TIMER) database. Results: High levels of mRNA expression of NDRG2 and NDRG3 were associated with a favorable prognosis in all GCs. In HER2(-) GC, NDRG1 was significantly associated with a poor prognosis of GC [hazard ratio (HR) = 1.65, 95% confidence interval (CI) = 1.16-2.33, p = 0.0046]. In HER2(+) GC, NDRG4 showed a poor prognosis (HR = 1.4, 95% CI: 1.06-1.85, p = 0.017). NDRG4 was an independent prognostic factor in recurrence-free survival by TCGA cohort. The low-risk NDRG-signature group displayed a significantly favorable survival outcome than the high-risk group (HR = 1.76, 95% CI: 1.2-2.59, p = 0.00385). The phosphorylated protein NDRG1 (NDRG1_pT346) displayed a favorable overall survival and was significantly associated with HER2 and phosphorylated HER2. Epidermis development was the top biological process (BP) for coexpressed genes associated with NDRG1 and NDRG4, while mitotic nuclear division and mitotic cell processes were the top BPs for NDRG2 and NDRG3, respectively. Overall, 6 CpGs of NDRG1, 4 CpGs of NDRG2, 3 CpGs of NDRG3 and 24 CpGs of NDRG4 were associated with significant prognosis. CD4(+) T-cells showed the highest correlation with NDRG4 (correlation = 0.341, p = 2.14e(-11)). Furthermore, BCL6 in follicular helper T-cells (Tfh) cells showed the highest association with NDRG4 (correlation = 0.438, p = 00e(+)00). Conclusions: This study analyzed the multilevel prognostic values and biological roles of the NDRG family in GC.

NDRG2 Expression and Mutation in Human Liver and Pancreatic Cancers

EXPRESSION OF NDRG2 IN PANCREAS,HEART AND KIDNEY OF DIABETIC AND NORMAL MICE

Expression Analysis of the NDRG2 Gene in Mouse Embryonic and Adult Tissues

Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer

Prognostic and Biological Role of the N-Myc Downstream-Regulated Gene Family in Hepatocellular Carcinoma.

Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients

Expression of NDRG2 in Human Colorectal Cancer and its Association with Prognosis.

Expression of Ngf Family and Their Receptors in Gastric Carcinoma: A Cdna Microarray Study

Expression of NDRG2 in human lung cancer and its correlation with prognosis

Prediction Of Colorectal Cancer Relapse And Prognosis By Tissue Mrna Levels Of Ndrg2

The NDRG1 Expression and the Prognosis in Patients of Gastric Carcinoma

Expression of CXCR7 and NDRG1 in Human Colorectal Tumors

The Genomic and Proteomic Profiles of NTRK Genes and Trk Receptors in Liver Hepatocellular Carcinoma.

Low NDRG2 Expression Predicts Poor Prognosis in Solid Tumors

NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma

Characterization Of The Prognostic Values Of The Ndrg Family In Gastric Cancer

Combined Aberrant Expression of NDRG2 and LDHA Predicts Hepatocellular Carcinoma Prognosis and Mediates the Anti-tumor Effect of Gemcitabine

A novel molecular marker for early detection and evaluating prognosis of gastric cancer: N-myc downstream regulated gene-1 (NDRG1).

Overexpression of NDRG1 leads to poor prognosis in hepatocellular carcinoma through mediating immune infiltration and EMT

[Expression of Neuropilin 2 in Human Colorectal Carcinoma and Its Correlation with Lymphangiogenesis and Lymphatic Metastasis of Tumor].

Expression of NRP-1 in gastric cancer tissue and its correlation with clinicopathological characteristics and prognosis